News
Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.
Vinay Prasad was reinstated as the head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) on 11 August. He had resigned on 29 July.1 “At the FDA’s ...
Pharmaceutical Technology on MSN6d
Prasad’s shock FDA return reignites regulatory uncertainty
Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.
This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...
Health and Me on MSN6d
FDA Vaccination Chief Vinay Prasad Returns To Job Within Days After Quitting Under Pressure, Who Is He?
Dr. Vinay Prasad, ousted as FDA’s top vaccine and gene therapy regulator amid political backlash, has been reinstated. Known ...
Trump’s first term also had an enduring impact on the courts, appointing 234 judges. By the end of that term, more than one-quarter of active federal judges were nominated by Trump, including three ...
Dr. Vinay Prasad, leader of the FDA division responsible for approving vaccines, is returning to the agency less than two ...
Dr. Vinay Prasad is resuming leadership of the FDA center that regulates vaccines and biotech therapies, a spokesperson for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback